New Results

Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon

Lydia J Finney, Nicholas Glanville, Hugo Farne, Julia Aniscenko, Peter Fenwick, Samuel V Kemp, Maria-Belen Trujillo-Torralbo, Maria Adelaide Calderazzo, Jadwiga A Wedzicha, Patrick Mallia, Nathan W Bartlett, Sebastian L Johnston, Aran Singanayagam
doi: https://doi.org/10.1101/2020.06.13.149039

Article usage

Article usage: June 2020 to May 2023

AbstractFullPdf
Jun 20203615142699
Jul 20201637211492
Aug 2020894278264
Sep 2020759170330
Oct 2020658123251
Nov 202032681144
Dec 2020319128224
Jan 2021219153115
Feb 202119514299
Mar 202124613396
Apr 2021171133156
May 2021136112105
Jun 20217313344
Jul 20211639134
Aug 2021869859
Sep 20211658985
Oct 2021668631
Nov 2021733322
Dec 2021551148
Jan 20226010938
Feb 2022378919
Mar 2022499415
Apr 2022437225
May 202217112
Jun 202232511
Jul 202241824
Aug 202223418
Sep 202236413
Oct 2022385316
Nov 2022432016
Dec 20222366
Jan 202331414
Feb 20231936
Mar 20232105
Apr 20231003
May 20231217
Back to top
Posted June 15, 2020.
Download PDF
Email
Inhaled corticosteroids downregulate the SARS-CoV-2 receptor ACE2 in COPD through suppression of type I interferon
Lydia J Finney, Nicholas Glanville, Hugo Farne, Julia Aniscenko, Peter Fenwick, Samuel V Kemp, Maria-Belen Trujillo-Torralbo, Maria Adelaide Calderazzo, Jadwiga A Wedzicha, Patrick Mallia, Nathan W Bartlett, Sebastian L Johnston, Aran Singanayagam
bioRxiv 2020.06.13.149039; doi: https://doi.org/10.1101/2020.06.13.149039
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area